| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.097 | 0.0009 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0009 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.002 |